Community News

Cohen Children’s Medical Center Performs First Gene Therapy Treatment For Thalassemia in NYS

The first administration in New York State of Zynteglo, recently approved by the FDA as a one-time gene therapy custom designed to treat the underlying genetic cause of transfusion-dependent beta-thalassemia in adult and pediatric patients, was performed earlier this month at Cohen Children’s Medical Center (Cohen) on an 8-year-old boy from Valley Stream, Long Island. […]